Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × Interleukin-15 × Clear all

Sponsor

Conditions

Sezary Syndrome 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Thyroid Neoplasms 1 Skin Neoplasms 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Lung Neoplasms 1 Leukemia-Lymphoma, Adult T-Cell 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma 1 Bronchiolitis Obliterans Syndrome 1 Breast Neoplasms 1

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡